Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
10.1371/journal.pmed.1001517
Saved in:
Similar Items
-
Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine
by: Russell, F.M., et al.
Published: (2014) -
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial
by: Russell, F.M., et al.
Published: (2014) -
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age
by: Russell, F.M., et al.
Published: (2014) -
pIgR and PECAM-1 bind to pneumococcal adhesins RrgA and PspC mediating bacterial brain invasion
by: Iovino, Federico, et al.
Published: (2017) -
Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
by: Russell, F.M., et al.
Published: (2014)